Updates in diagnosis and treatment of acromegaly

74Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

Abstract

Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised.

Cite

CITATION STYLE

APA

Zahr, R., & Fleseriu, M. (2018, September 1). Updates in diagnosis and treatment of acromegaly. European Endocrinology. Touch Briefings. https://doi.org/10.17925/EE.2018.14.2.57

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free